Identification of ginkgolide B metabolites in urine and rat liver cytochrome P450 enzymes responsible for their formation in vitro

被引:24
作者
Wang, Dian-lei [1 ,2 ]
Liang, Yan [1 ]
Chen, Wei-dong [1 ]
Xie, Lin [1 ]
Wang, Guang-ji [1 ]
Liu, Xiao-dong [1 ]
机构
[1] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China
[2] Anhui Coll Tradit Chinese Med, Sch Pharm, Hefei 230038, Peoples R China
关键词
ginkgolide B; metabolism; cytochrome P450 enzymes; urine; liver microsomes; rat;
D O I
10.1111/j.1745-7254.2008.00758.x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: To identify metabolites of ginkgolide B in rat urine, the predominant metabolism of ginkgolide B and the major cytochrome (CYP) P450 enzymes responsible for the metabolism of ginkgolide B in rat liver microsomes. Methods: A liquid chromatography quadrupole mass spectrometer and liquid chromatography ion-trap-time-of-fight mass spectrometer with electrospray ionization in negative-ion mode were used for the structure elucidation of metabolites in rat urine and liver microsome incubation. Various selective CYP450 inhibitors were applied to investigate their effects on the metabolism of ginkgolide B and the formation of the major metabolite in rat liver microsomes. Results: Three metabolites were identified in rat urine. One hydroxyl metabolite of ginkgolide B were identified in rat liver microsomes, and quinidine uncompetitively inhibited the formation of the metabolite; its inhibitor constant (K-i) value for the inhibition of hydroxyl metabolite was estimated to be 8 mu mol/L, while alpha-naphthoflavone, ketoconazole, sulfaphenazole, and diethyldithiocarbamate had no inhibitory effects. Conclusion: Ginkgolide B was metabolized to its hydroxyl metabolite in rats, and CYP2D6 was the major rat CYP isoform responsible for the ginkgolide B metabolism in rat liver microsomes.
引用
收藏
页码:376 / 384
页数:9
相关论文
共 13 条
[1]   Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β1-42 [J].
Bate, Clive ;
Salmona, Mario ;
Williams, Alun .
JOURNAL OF NEUROINFLAMMATION, 2004, 1 (1)
[2]  
Beck J C, 1991, Autoimmunity, V9, P225, DOI 10.3109/08916939109007648
[3]  
Braquet P, 1986, Adv Prostaglandin Thromboxane Leukot Res, V16, P179
[4]   Pharmacokintics of the Ginkgo Bfollowing intravenous administration of Ginkgo B emulsion in rats [J].
Chen, Wei-Dong ;
Liang, Yan ;
Xie, Lin ;
Lu, Tong ;
Liu, Xiao-Dong ;
Wang, Guang-Ji .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (01) :1-5
[5]   Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides:: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts [J].
Koch, E .
PHYTOMEDICINE, 2005, 12 (1-2) :10-16
[6]   The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat [J].
Liu, XH ;
Eun, BL ;
Silverstein, FS ;
Barks, JDE .
PEDIATRIC RESEARCH, 1996, 40 (06) :797-803
[7]  
Liu XQ, 2003, ACTA PHARMACOL SIN, V24, P263
[8]   Metabolism and metabolic inhibition of gambogic acid in rat liver microsomes [J].
Liu, Yi-tong ;
Hao, Kun ;
Liu, Xiao-quan ;
Wang, Guang-ji .
ACTA PHARMACOLOGICA SINICA, 2006, 27 (09) :1253-1258
[9]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[10]   PAF ANTAGONIST GINKGOLIDE-B REDUCES POSTISCHEMIC NEURONAL DAMAGE IN RAT-BRAIN HIPPOCAMPUS [J].
OBERPICHLER, H ;
SAUER, D ;
ROSSBERG, C ;
MENNEL, HD ;
KRIEGLSTEIN, J .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1990, 10 (01) :133-135